Hence, in the present study, we investigated the potential of ESR1, ESR2, and PGR as predictive and prognostic biomarkers in multiple cancer types from an immuno-oncological perspective based on bioinformatics analysis to provide a reference for future studies and the application of immunotherapies. The gene discussed is ESR1; the disease is cancer.